Thyroid disorder decisions — 2026

The Veteran's claim for an evaluation in excess of 10 percent for hypothyroidism was denied. The Board found that the symptoms did not warrant a higher rating under either the old or new criteria, and thus denied the claim.

The Veteran's hypothyroidism is rated at 30 percent, but no higher, as her symptoms are controlled by medication and do not meet the criteria for a 50% rating due to lack of myxedema.

The Veteran's claim for service connection for obstructive sleep apnea was granted with an effective date of October 3, 2016. The claims for alopecia and acquired hypothyroidism were remanded due to the need for additional medical opinions.

The Veteran's service connection for hypothyroidism is granted with an effective date of August 17, 1998. Service connection for hypogonadism was denied.

The Board has remanded the case due to an inextricably intertwined issue of assigning an initial rating for hypothyroidism effective August 17, 1998. The earlier effective date claim will be considered after this matter is resolved.

The Board has remanded the Veteran's claims for an effective date prior to August 27, 2024, for horizontal neck scar, residuals of thyroidectomy and a compensable rating for thyroid enlargement, non-toxic thyroidectomy (previously rated as hypothyroidism).

The Board has granted service connection for hypothyroidism as secondary to the Veteran's service-connected rheumatoid arthritis.

The Board has determined that the Veteran's PTSD, hypertension, DMII, hypothyroidism, and skin condition are related to his active-duty service. However, further development is needed for the claims of erectile dysfunction and skin condition due to potential exposure to toxins during service.

The Veteran's coronary artery disease is rated at 100 percent effective April 13, 2023.,The Veteran's other trauma and stressor related disorder is rated at 70 percent effective April 13, 2023.

The Board has granted service connection for thymoma, thyroid nodule, Myasthenia gravis, splenic calcified granuloma, hepatic calcified granuloma, and calcified pleural granuloma, all of which are related to toxic environmental exposures during active naval service.

The Board denied service connection for prostate cancer and associated residuals (claimed as testicular cancer) and thyroid cancer, finding that the evidence did not support a link to military service or exposure.

The Veteran's bladder cancer, hypertension, Bowen's disease (skin condition), thyroid condition (hypothyroidism/hyperthyroidism), back disability, left hip disability, osteopenia/osteoporosis, and right foot vascular disorder are all granted as presumptively related to herbicide exposure. The Veteran's service-connected bilateral knee disabilities are also found to be secondary to these conditions.

The Veteran's claims for service connection for bilateral hearing loss, deviated septum, and obstructive sleep apnea have been denied. The Veteran has had his service-connected hypothyroidism granted with an effective date of February 13, 2023. His liver disability and eczema claims are remanded.

The Veteran's initial claim for service-connected hypothyroidism was granted with a 30 percent disability rating, which was later reduced to 10 percent. The reduction is upheld as proper due to CUE in the original decision. The Veteran's current 10 percent rating for hypothyroidism is denied.

The Veteran's claims for service connection are granted for hypothyroidism and atherosclerotic cardiovascular disease due to herbicide exposure. The remaining issues of service connection, including those related to the bilateral lower extremity nerve condition, vertigo, major neurocognitive disorder, and posttraumatic complex partial seizures (head injury residuals), are remanded for further development.

The Veteran's hypothyroidism is granted as secondary to his service-connected thyroid cancer, which was caused by exposure to herbicide agents during his naval service.

The Veteran's hypothyroidism is not rated higher than a compensable rating.,Prior to October 16, 2025, the Veteran's sinusitis was not rated higher than 10 percent. From October 16, 2025, it has been rated at 30 percent.

The Board has granted service connection for sleep apnea as secondary to the Veteran's service-connected hypothyroidism, finding that reasonable doubt should be resolved in favor of the Veteran.

The Veteran's appeal for service connection on five different conditions has been dismissed due to the withdrawal of the appeal by his representative.

The Veteran's claim for service connection for Hashimoto's thyroiditis, to include hypothyroidism (claimed as Hashimoto's disease and thyroid condition) was granted in a June 2025 rating decision. The appeal is dismissed as moot since the issue has been resolved.